Form 0920-24AA Lead Evaluator Survey

Lead Evaluator Survey

Form Approve OMB No: 0920-1431 Exp. Date: 04-30-2027

The public reporting burden of this information collection is estimated at 30 minutes, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor; a person is only required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NW, MS H21-8, Atlanta, GA 30333; Attn: PRA (0920-1431).

INTRODUCTION

1. In which state/territory is your RPE organization doing work?

2. Does your RPE organization employ internal evaluation staff, external evaluation staff (e.g., contractors), or both internal and external evaluation staff?

   1. Internal evaluation staff

   2. External evaluation staff

   3. Internal and external evaluation staff

3. If your organization employs external evaluation staff, please indicate the type of employer:

   1. Contracting agency (please provide name)

   2. University (please provide name)

   3. Other (please provide name)

PROGRESS TOWARD GOALS

4. What evaluation measure(s) is being used to monitor progress towards NOFO strategies and activities?

Strategies and activities	Associated evaluation measure
Build internal capacity to facilitate and monitor implementation
Build capacity for partner organizations
Conduct or leverage a primary prevention capacity assessment with a focus on health for all, and especially for those at greatest risk.
Participate in CDC sponsored activities
Develop or enhance existing State/Territory/Tribal Action Plan with partners
Leverage multi-sector partners towards SV prevention
Engage multi-sector partners including but not limited to SA and Tribal Coalitions

Identifying, implementing, and adapting SV prevention strategies at the community and societal level focused on reducing disparities
Gather and synthesize publicly available data
Use data to identify and select prevention strategies
Develop and implement an evaluation plan focused on the health for all, and especially for those at greatest risk.
Increase access to and use of monitoring and evaluation data to improve SV prevention implementation

5. To what extent has your RPE organization made progress in the following short-term outcomes? Please base your responses on your most recent evaluation findings.

	Level of Progress					How this is measured
	Not yet measured	No progress	Very little progress	Moderate progress	Substantial progress
Increased capacity/understanding of capacity to implement and evaluate primary prevention of SV at the community- and societal- levels within SHDs/in Indian Country
Increased capacity to promote and incorporate health for all, and especially for those at greatest risk program activities relevant to SV prevention among partner organizations
Increased partner and community awareness of states/territories/tribal efforts to prevent SV and the disproportionate burden of SV
Increased partner and community awareness of effective primary prevention strategies and the disparate burden of SV
Increased coordination and collaboration among partners and between SHDs, SA coalitions, Tribal SA coalitions, representatives from underserved

communities and other sectors to prevent SV
Increased community and society-level implementation of SV prevention strategies
Increased implementation of prevention strategies among communities and populations with disproportionately high rates of SV
Increased implementation of prevention strategies that seek to prevent SV by addressing social and structural determinants of health
Increased awareness of availability of data to understand inequities within tribal populations and communities with disproportionately high rates of SV
Increased access and use of data to understand inequities within populations and communities with disproportionately high rates of SV
Increased monitoring and evaluation activities and sharing of data related to SV prevention

6. Please provide a brief explanation of any challenges faced related to measurement of short- term outcomes (750 characters).

7. To what extent has your RPE organization made progress in the following intermediate-term outcomes? Please base your responses on your most recent evaluation findings.

	Level of Progress					How this is measured
	Not yet measured	No progress	Very little progress	Moderate progress	Substantial progress
Increased capacity for statewide program

implementation and SV prevention
Increased partner support to implement, evaluate, and adapt state- and community- level strategies to prevent SV
Increased reach of prevention strategies that impact communities and populations with disproportionately high rates of SV
Increase in number of community- and societal- level strategies that promote health for all, and especially for those at greatest risk and reduce inequities in SV by addressing social and structural determinants of health
Increase in protective factors and decrease in risk factors associated with SV
Increased access to data to understand inequities within tribal populations and communities with disproportionately high rates of SV
Increased use of data-driven decision making to reduce inequities impacting populations and communities with disproportionately high rates of SV
Increased state- and community-level monitoring of trends in SV outcomes and SDOH

8. Please provide a brief explanation of any challenges faced related to measurement of intermediate-term outcomes. (750 characters)

DATA USE AND ACCESS

9. What barriers has your RPE organization experienced with respect to accessing data? How are you addressing those barriers? (750 characters)

10. What facilitators has your RPE organization experienced with respect to accessing data? (750 characters)

EVALUATION CAPACITY AND PROGRESS

11. As of today, how would you describe the status of your RPE organization’s evaluation activities?

    1. Experiencing significant delays

    2. Experiencing minor delays

    3. On track

12. What challenges have affected your RPE organization’s evaluation progress to date? How are you addressing those challenges? (1000 characters)

13. What has facilitated your RPE organization’s evaluation progress to date? (1000 characters)

14. Please describe how key partners have supported your RPE organization's evaluation capacity. (750 characters)

15. Please describe any changes made to your evaluation plan and the reason for those changes (e.g., changes in evaluation design, data collection, analysis methods, outcomes and indicators, product dissemination). (1,000 characters)

16. To what extent has your RPE organization used its evaluation data?

    1. Not at all

    2. A little

    3. Somewhat

    4. A great deal

17. What barriers has your RPE organization experienced with respect to using evaluation data for continuous program improvement? How are you addressing those barriers? (750 characters)

18. What facilitators has your RPE organization experienced with respect to using evaluation data for continuous program improvement? (750 characters)

19. How have evaluation findings been used to inform your RPE organization’s program activities? (750 characters)

20. How is your RPE organization aligning its program- and policy-level evaluation with state/territory-level evaluation? (750 characters)

21. How would you rate the capacity of your RPE organization’s sub-recipients to evaluate sexual violence prevention activities?

    1. Extremely low

    2. Moderately low

    3. Adequate

    4. Moderately high

    5. Extremely high

22. What factors have impacted your RPE organization's sub-recipients' capacity to evaluate SV prevention activities? (750 characters)

23. What evaluation-related trainings has your RPE organization provided to its partners? Which types of partners (e.g., health services, government, education, law enforcement, etc.) participated in these trainings?

Training Provided	Types of Partner(s) Participated

24. What evaluation products has your RPE organization developed? How does your RPE organization plan to disseminate its evaluation products, and to which audiences? (1200 characters)

TECHNICAL ASSISTANCE

25. Which types of technical assistance and support from the CDC and technical assistance partners have been useful to your RPE organization? (1000 characters)

26. How could technical assistance and support from CDC and technical assistance partners be improved? (1000 characters)

CONCLUSION

27. Thank you so much for taking the time to complete this survey! If you have any additional comments on evaluation, please provide them here. (1000 characters)